CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung ...

“They don't even agree on how precipitation will change in the future.” One project Monteleoni worked on uses machine learning algorithms to combine the predictions of the approximately 30 ...

We're celebrating 25 years of work to advance a bold vision for a just and inclusive democracy and economy that reflects a growing and diversifying nation. Read Taifa Smith Butler's reflection on ...

The Agent2Agent (A2A) protocol addresses a critical challenge in the AI landscape: enabling gen AI agents, built on diverse frameworks by different companies running on separate servers, to ...